At SalubrisBio, our mission is to develop first-in-class biologics that improve the health and quality of life of people living with complicated diseases.

We have the passion, commitment, and expertise needed to drive our assets through all phases of clinical development to deliver novel biologic therapies to patients. We believe we can achieve our ambitions by embracing challenges and valuing teamwork.

SalubrisBio is the first company in the world to bring a bispecific antibody into clinical trials in a cardiovascular indication. We endeavor to make this the first of many global innovation achievements.

At SalubrisBio we have passion, commitment, and enthusiasm for innovative drug discovery and development. We embrace challenges and value teamwork to solve problems and achieve our ambitions.

 

Salubris Biotherapeutics, Inc. (or SalubrisBio) is a science-driven biotechnology company dedicated to the discovery and global development of novel complex biologics for the treatment of cancer and cardiovascular diseases. We strive to develop novel therapeutic molecules which provide clinically meaningful improvements in disease burden and quality of life to patients with significant medical needs. SalubrisBio is seeking highly motivated individuals with exceptional abilities to join our antibody drug research and development programs.